PGIM India Healthcare Fund
For Exits beyond 90 days from date of allotment of units : NIL
The scheme will be predominantly invested in equity and equity related securities of healthcare and pharmaceutical companies. The aim of the scheme is to seek long-term capital appreciation from an actively managed portfolio. The fund may consider investing in various sectors within the healthcare industry, including healthcare services and healthcare manufacturing. Healthcare services include, but are not limited to, pharmacy, diagnostics, hospitals and health insurance. Healthcare manufacturing encompasses CRAMS (Contract Research and Manufacturing Services), medical devices, specialty chemicals, formulations and API (Active Pharmaceutical Ingredient), among others. The portfolio will be built utilizing a combination of top-down and bottom-up portfolio construction process, focusing on the fundamentals of each stock, including quality of management.
PGIM India Healthcare Fund provides a compelling opportunity for investors to benefit from India’s burgeoning healthcare sector which benefits from low cost, innovation, growing awareness for health insurance, rising FDI inflows and growing medical tourism and more. Benchmarked against BSE Healthcare TRI, the fund will invest a minimum of 80% in stocks of pharmaceutical and healthcare companies, up to 20% in other equities/debt and money market, REITs & InvITs (up to 10%) and foreign securities including overseas ETFs up to 20%).
- Benefit from rising demand for medical services due to ageing population, greater health awareness and increased government spending.
- Emerging trends like age segments like AI based diagnostics, med-tech, telemedicine, shift towards preventive healthcare, medical tourism and more, bodes well for the sector.
- Opportunity to participate in a theme which is relatively immune to economic downturns.
- Diversified investment opportunity within healthcare and ancillary sectors.
- Benefit from rising income levels and a changing attitude towards preventive healthcare.
- A multi decadal structural theme to benefit from rising FDI inflows and government expenditure.
- Benefit from increased government spending which is projected to reach 2.5% of the country's GDP by 2025. (Source: www.ibef.org)
You can invest through multiple options:
- Website: You can invest through PGIM India Website by creating your profile and submitting identity details, and bank account information, and becoming KYC compliant.
- RIA/MFD: You can also invest through a Registered Investment Adviser or Mutual Fund distributor registered with SEBI/AMFI.
- Industry Portal: You can also invest through MF Utility or MF Central portals.
- Do consult your financial advisor before investing to understand if the fund fits into your risk profile.
- SIP: Any date of the month or quarter, as applicable.
- STP: Daily, Weekly, Monthly and Quarterly.
- SWP: Monthly, Quarterly and Annually.
- You can invest lumpsum as well as through SIP mode.
- The minimum application amount under this fund is Rs 5,000 for a lumpsum transaction. You can invest a minimum of Rs 1,000 as additional investment.
- You need to commit at least 5 instalments (monthly or quarterly) with a minimum of Rs 1,000 per instalment if you invest through SIP.
- Holding Period (To qualify for LTCG): 12 months
- Short Term Capital Gains Tax: 20%
- Long Term Capital Gains Tax: 12.5% (with an exemption up to INR 1.25 lakhs)
Plus surcharge and cess as may be applicable on the above rates.
- Long term capital growth
- Investment in equity and equity related securities of pharmaceutical and healthcare companies.
- Degree of risk - VERY HIGH
The risk of the Benchmark is
Very High
The risk of the Benchmark is Very High
